vs

Side-by-side financial comparison of Alset Inc. (AEI) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.3M, roughly 1.3× Alset Inc.). On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -85.4%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-6.1M). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -53.7%).

Alset Global GmbH is an Austrian technology and engineering company based in Graz that specialises in hydrogen-based clean mobility products. Alset Global is known for developing a Hybrid Hydrogen internal combustion engine that can run on either pure petrol, pure hydrogen or a combination of both. This technology offers a sustainable and clean alternative to petrol-based internal combustion engines. The technology has been developed to create an alternative technology to meet new emission ta...

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

AEI vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.3× larger
IVF
$1.8M
$1.3M
AEI
Growing faster (revenue YoY)
IVF
IVF
+108.0% gap
IVF
22.6%
-85.4%
AEI
More free cash flow
IVF
IVF
$4.3M more FCF
IVF
$-1.8M
$-6.1M
AEI
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-53.7%
AEI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
AEI
AEI
IVF
IVF
Revenue
$1.3M
$1.8M
Net Profit
$-2.6M
Gross Margin
35.2%
Operating Margin
-93.1%
Net Margin
-150.5%
Revenue YoY
-85.4%
22.6%
Net Profit YoY
-1491.5%
-62.2%
EPS (diluted)
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEI
AEI
IVF
IVF
Q4 25
$1.3M
Q3 25
$998.8K
$1.8M
Q2 25
$1.1M
$1.9M
Q1 25
$1.1M
$1.6M
Q4 24
$8.9M
$1.7M
Q3 24
$5.0M
$1.4M
Q2 24
$1.1M
$1.8M
Q1 24
$6.1M
$1.6M
Net Profit
AEI
AEI
IVF
IVF
Q4 25
Q3 25
$1.5M
$-2.6M
Q2 25
$-8.2M
$-5.3M
Q1 25
$-8.3M
$-17.4M
Q4 24
$2.3M
$-3.6M
Q3 24
$1.7M
$-1.6M
Q2 24
$-1.2M
$-2.2M
Q1 24
$-6.8M
$-1.6M
Gross Margin
AEI
AEI
IVF
IVF
Q4 25
35.2%
Q3 25
24.3%
Q2 25
23.3%
Q1 25
27.2%
35.2%
Q4 24
51.4%
41.4%
Q3 24
40.5%
31.0%
Q2 24
26.4%
53.1%
Q1 24
23.5%
45.3%
Operating Margin
AEI
AEI
IVF
IVF
Q4 25
Q3 25
-258.2%
-93.1%
Q2 25
-250.7%
-160.4%
Q1 25
-368.1%
-1042.1%
Q4 24
21.5%
-202.0%
Q3 24
-19.4%
-90.7%
Q2 24
-249.3%
-100.9%
Q1 24
-37.2%
-95.7%
Net Margin
AEI
AEI
IVF
IVF
Q4 25
Q3 25
151.4%
-150.5%
Q2 25
-748.1%
-283.6%
Q1 25
-780.1%
-1060.1%
Q4 24
26.0%
-211.3%
Q3 24
34.6%
-113.8%
Q2 24
-109.9%
-122.2%
Q1 24
-111.2%
-101.3%
EPS (diluted)
AEI
AEI
IVF
IVF
Q4 25
Q3 25
$0.05
$-0.77
Q2 25
$-0.71
$-13.30
Q1 25
$-0.78
$-12.53
Q4 24
$0.24
$14.86
Q3 24
$0.19
$-15.11
Q2 24
$-0.13
$-22.39
Q1 24
$-0.73
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEI
AEI
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$25.2M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$121.1M
$5.8M
Total Assets
$136.6M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEI
AEI
IVF
IVF
Q4 25
$25.2M
Q3 25
$25.5M
Q2 25
$25.6M
Q1 25
$25.2M
Q4 24
$27.2M
Q3 24
$16.7M
Q2 24
$18.9M
Q1 24
$23.7M
Total Debt
AEI
AEI
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
$116.5K
Q4 24
$123.1K
$7.5M
Q3 24
$137.9K
Q2 24
$137.8K
Q1 24
$145.8K
Stockholders' Equity
AEI
AEI
IVF
IVF
Q4 25
$121.1M
Q3 25
$155.7M
$5.8M
Q2 25
$72.8M
$2.6M
Q1 25
$76.4M
$3.3M
Q4 24
$81.3M
$12.7M
Q3 24
$84.2M
$-23.3K
Q2 24
$79.4M
$1.4M
Q1 24
$81.7M
$10.2K
Total Assets
AEI
AEI
IVF
IVF
Q4 25
$136.6M
Q3 25
$169.1M
$18.8M
Q2 25
$86.0M
$19.3M
Q1 25
$90.5M
$31.7M
Q4 24
$96.8M
$46.4M
Q3 24
$98.8M
$17.0M
Q2 24
$93.5M
$17.8M
Q1 24
$96.7M
$17.3M
Debt / Equity
AEI
AEI
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
0.00×
Q4 24
0.00×
0.59×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEI
AEI
IVF
IVF
Operating Cash FlowLast quarter
$-5.9M
$-1.8M
Free Cash FlowOCF − Capex
$-6.1M
$-1.8M
FCF MarginFCF / Revenue
-467.7%
-101.6%
Capex IntensityCapex / Revenue
13.4%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.8M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEI
AEI
IVF
IVF
Q4 25
$-5.9M
Q3 25
$883.4K
$-1.8M
Q2 25
$-2.6M
$-1.7M
Q1 25
$-3.8M
$-3.5M
Q4 24
$5.2M
$-617.4K
Q3 24
$-2.9M
$-640.8K
Q2 24
$-4.4M
$-1.5M
Q1 24
$-1.5M
$-260.6K
Free Cash Flow
AEI
AEI
IVF
IVF
Q4 25
$-6.1M
Q3 25
$822.4K
$-1.8M
Q2 25
$-2.7M
$-1.7M
Q1 25
$-3.8M
$-3.6M
Q4 24
$5.1M
$-696.3K
Q3 24
$-2.9M
Q2 24
$-4.4M
$-1.5M
Q1 24
$-1.5M
$-310.3K
FCF Margin
AEI
AEI
IVF
IVF
Q4 25
-467.7%
Q3 25
82.3%
-101.6%
Q2 25
-245.9%
-92.6%
Q1 25
-357.3%
-216.9%
Q4 24
56.5%
-40.6%
Q3 24
-58.2%
Q2 24
-392.3%
-82.3%
Q1 24
-24.8%
-19.7%
Capex Intensity
AEI
AEI
IVF
IVF
Q4 25
13.4%
Q3 25
6.1%
0.5%
Q2 25
7.6%
0.5%
Q1 25
5.7%
0.9%
Q4 24
1.1%
4.6%
Q3 24
0.6%
0.0%
Q2 24
3.0%
3.0%
Q1 24
0.0%
3.2%
Cash Conversion
AEI
AEI
IVF
IVF
Q4 25
Q3 25
0.58×
Q2 25
Q1 25
Q4 24
2.22×
Q3 24
-1.66×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons